169 related articles for article (PubMed ID: 23541566)
21. The burden of rare cancers in Europe.
Gatta G; Capocaccia R; Trama A; Martínez-García C;
Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452
[TBL] [Abstract][Full Text] [Related]
22. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
23. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
[TBL] [Abstract][Full Text] [Related]
24. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
[TBL] [Abstract][Full Text] [Related]
25. Second cancers in patients with neuroendocrine tumors.
Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
PLoS One; 2013; 8(12):e86414. PubMed ID: 24392036
[TBL] [Abstract][Full Text] [Related]
26. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours.
Lepage C; Bouvier AM; Faivre J
Eur J Endocrinol; 2013 Apr; 168(4):R77-83. PubMed ID: 23349330
[TBL] [Abstract][Full Text] [Related]
27. Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition.
Diets IJ; Nagtegaal ID; Loeffen J; de Blaauw I; Waanders E; Hoogerbrugge N; Jongmans MC
Br J Cancer; 2017 Jan; 116(2):163-168. PubMed ID: 27959889
[TBL] [Abstract][Full Text] [Related]
28. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
Allan B; Davis J; Perez E; Lew J; Sola J
Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
[TBL] [Abstract][Full Text] [Related]
29. Incidence and survival of rare urogenital cancers in Europe.
Visser O; Adolfsson J; Rossi S; Verne J; Gatta G; Maffezzini M; Franks KN;
Eur J Cancer; 2012 Mar; 48(4):456-64. PubMed ID: 22119351
[TBL] [Abstract][Full Text] [Related]
30. Incidence, survival and prevalence of myeloid malignancies in Europe.
Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.
Ito T; Sasano H; Tanaka M; Osamura RY; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Nakamura K; Igarashi H; Jensen RT; Wiedenmann B; Imamura M
J Gastroenterol; 2010 Feb; 45(2):234-43. PubMed ID: 20058030
[TBL] [Abstract][Full Text] [Related]
32. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
[TBL] [Abstract][Full Text] [Related]
33. Data quality in rare cancers registration: the report of the RARECARE data quality study.
Trama A; Marcos-Gragera R; Sánchez Pérez MJ; van der Zwan JM; Ardanaz E; Bouchardy C; Melchor JM; Martinez C; Capocaccia R; Vicentini M; Siesling S; Gatta G;
Tumori; 2017 Jan; 103(1):22-32. PubMed ID: 27716878
[TBL] [Abstract][Full Text] [Related]
34. Descriptive epidemiological study of rare, less common and common cancers in Western Australia.
Bilkey GA; Trevithick RW; Coles EP; Girschik J; Nowak KJ
BMC Cancer; 2021 Jul; 21(1):779. PubMed ID: 34233636
[TBL] [Abstract][Full Text] [Related]
35. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
Caldarella A; Crocetti E; Paci E
Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
[TBL] [Abstract][Full Text] [Related]
36. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours.
McMullen T; Al-Jahdali A; de Gara C; Ghosh S; McEwan A; Schiller D
Can J Surg; 2017 Jun; 60(3):192-197. PubMed ID: 28327275
[TBL] [Abstract][Full Text] [Related]
38. Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population-based cancer registries.
Balmant NV; de Souza Reis R; de Oliveira Santos M; de Camargo B; Gatta G
Cancer; 2019 Aug; 125(15):2638-2646. PubMed ID: 31013367
[TBL] [Abstract][Full Text] [Related]
39. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
Metildi C; McLemore EC; Tran T; Chang D; Cosman B; Ramamoorthy SL; Saltzstein SL; Sadler GR
Am Surg; 2013 Oct; 79(10):1068-74. PubMed ID: 24160801
[TBL] [Abstract][Full Text] [Related]
40. Survival from rare cancer in adults: a population-based study.
Gatta G; Ciccolallo L; Kunkler I; Capocaccia R; Berrino F; Coleman MP; De Angelis R; Faivre J; Lutz JM; Martinez C; Möller T; Sankila R;
Lancet Oncol; 2006 Feb; 7(2):132-40. PubMed ID: 16455477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
